Parmelee et al., 1982 - Google Patents
Amino acid sequence of amyloid-related apoprotein (apoSAA1) from human high-density lipoproteinParmelee et al., 1982
- Document ID
- 12037486260459729806
- Author
- Parmelee D
- Titani K
- Ericsson L
- Eriksen N
- Benditt E
- Walsh K
- Publication year
- Publication venue
- Biochemistry
External Links
Snippet
Materials and Methods Amyloid-related apoprotein SAA, was isolated from the HDL3 fraction of a pool of human sera with elevated AA immunoreactivity, as described by Eriksen & Benditt (1980) with certain modifications as follows. The HDL3 fractions were dialyzed …
- 108010083590 Apoproteins 0 title description 4
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Parmelee et al. | Amino acid sequence of amyloid-related apoprotein (apoSAA1) from human high-density lipoprotein | |
| Chesebro et al. | Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain | |
| Orelle et al. | Human pancreatitis-associated protein. Messenger RNA cloning and expression in pancreatic diseases. | |
| Todorov et al. | Characterization of a cancer cachectic factor | |
| Betsholtz et al. | Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation | |
| Demmer et al. | Molecular cloning of ERp29, a novel and widely expressed resident of the endoplasmic reticulum | |
| Tobe et al. | Cloning and characterization of the cDNA encoding a novel brain‐specific 14‐kDa protein | |
| JPH09510715A (en) | Antifeedant peptide | |
| US20100151589A1 (en) | Glycoproteins Having Lipid Mobilising Properties and Therapeutic Applications Thereof | |
| US5859189A (en) | Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes | |
| JPH07507684A (en) | Novel polypeptides with NMDA receptor activity, nucleic acids encoding these polypeptides, and uses | |
| US8618051B2 (en) | Vesiculins | |
| JP2001522228A (en) | Activity-dependent neurotrophic factor III (ADNF III) | |
| CA2390652C (en) | Human circulating virus-inhibiting peptide (virip) and its use | |
| JPH04500603A (en) | Cloned nephritis antigen | |
| EP0454765A1 (en) | Pregnancy specific proteins applications | |
| JPH1169985A (en) | Crfg-1a as target and marker of chronic renal insufficiency | |
| Volknandt et al. | A synaptic vesicle specific GTP-binding protein from ray electric organ | |
| JP2004008027A (en) | Novel peptide having cAMP production activity | |
| Li et al. | Cancer-associated lactate dehydrogenase is a tyrosylphosphorylated form of human LDH-A, skeletal muscle isoenzyme | |
| US6809175B1 (en) | Cadherin derived growth factor and its use | |
| JP2002300891A (en) | New compound | |
| Boosman et al. | Partial primary structures of human and murine macrophage colony stimulating factor (CSF-1) | |
| JP3629759B2 (en) | Proteasome activator | |
| US20070173457A1 (en) | Tau-conotoxin peptides |